Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
67 /100
COMPONENT-LIMITED
Score updated Aug 28, 2026

BDRX — Biodexa Pharmaceuticals Plc Dilution Risk Tracker

Track BDRX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track BDRX — Get alerts when the score changes →

As of August 28, 2026, Biodexa Pharmaceuticals Plc (BDRX) has a DilutionWatch DilutionScore of 67/100, rated HIGH dilution risk. This is a component-limited score because one or more material inputs are unavailable or not applicable. Biodexa Pharmaceuticals Plc has a market capitalization of $2.59M, 225.82B shares outstanding, 8 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
80
💰 Cash Runway
40
📊Float Risk
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 5%
📉 Score Deterioration model 10%
• Score in HIGH risk zone (67/100)
🔔 Track BDRX — Get forecast alerts →

Market Data

Market Cap$2.59M
Shares Outstanding225.82B
FloatN/A
Cash$11.48M
Debt$82.1K
Short InterestN/A

Institutional Holdings

8 institutional holders · 63.2K shares
#1 Sabby Management, LLC 38.1K shares
#2 Armistice Capital, LLC 20.0K shares
#3 Gamma Investing LLC 2.8K shares
+ 5 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest24.8K
Days to Cover1.0
% of FloatN/A
FINRA data as of Jul 31, 2026

Recent SEC Activity

No recent SEC insights

Recent News

No recent news
Track BDRX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking BDRX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

Score Coverage Note

More Research for BDRX
BDRX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.